Relationship of recurrence rate with some characteristics in patients with thyroid carcinoma

Relationship of recurrence rate with some characteristics in patients with thyroid carcinoma

Background: Determining the clinical and subclinical characteristics related to the recurrence status in patients with a thyroid carcinoma has great significance for prognosis, prediction of recurrence and monitoring of treatment outcomes. This study aimed to determine the association between recurr...

Full description

Bibliographic Details
Main Authors:	Tri D M. Bui, Chi D P. Bui, Hiep T Bui, Trung H Nguyen, Minh D Tong, Dung T N. Nguyen, Thanh D Bui, Viet Q Tran, Hiep T Nguyen
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Indian Journal of Endocrinology and Metabolism
Subjects:	braf v600e mutation lymph node metastasis recurrence rate thyroid carcinoma
Online Access:	http://www.ijem.in/article.asp?issn=2230-8210;year=2023;volume=27;issue=6;spage=544;epage=551;aulast=M.

Similar Items

Risk factors for central lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study
by: Jiachen Du, et al.
Published: (2023-11-01)

Predicting factors of central lymph node metastasis and BRAF V600E mutation in Chinese population with papillary thyroid carcinoma
by: Sheng Li Zhou, et al.
Published: (2021-07-01)

Characteristics of central compartment lymph node metastasis in patients with unilateral cN0 papillary thyroid carcinoma and prophylactic dissection
by: LIU Wei, WANG Cong, XUE Anwei, ZHAO Junjie, WANG Zhenglin
Published: (2021-03-01)

BRAF V600E and lymph node metastases in papillary thyroid cancer
by: Pan Chen, et al.
Published: (2020-10-01)

Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Cancer With BRAF V600E Mutation
by: Ying Han, et al.
Published: (2022-06-01)

Prevalence and Impact of BRAF mutation in patients with concomitant papillary thyroid carcinoma and Hashimoto’s thyroiditis: a systematic review with meta-analysis
by: Lukasz Janicki, et al.
Published: (2023-11-01)

Intraglandular dissemination: a special pathological feature
by: Yubi Zhang, et al.
Published: (2024-07-01)

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study
by: Li Q, et al.
Published: (2018-05-01)

A comprehensive prediction model for central lymph node metastasis in papillary thyroid carcinoma with Hashimoto’s thyroiditis: BRAF may not be a valuable predictor
by: Yanwei Chen, et al.
Published: (2024-09-01)

Risk factors of cervical central lymph node metastasis in stage T1a unifocal papillary thyroid carcinoma
by: Hai-ying Tian, et al.
Published: (2024-10-01)

Predictive Factors for Level V Lymph Node Metastases in Papillary Thyroid Carcinoma with BRAFV600E Mutation and Clinicopathological Features
by: Li G, et al.
Published: (2020-05-01)

Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer
by: Zhongzhi Wang, et al.
Published: (2023-02-01)

Thyroglobulin Antibody (TgAb) Positive is an Independent Risk Factor for Lymph Node Metastasis in Patients with Differentiated Thyroid Carcinoma
by: Lai Y, et al.
Published: (2023-12-01)

Younger Than 55 Years Old and BRAF V600E Mutation are Risk Factors for Lymph Node Metastasis in Papillary Thyroid Carcinomas ≤1.0 cm but Not in >1.0 cm
by: Lai Y, et al.
Published: (2023-04-01)

Radiofrequency Ablation for Recurrent Papillary Thyroid Carcinoma at the Central Compartment Node: A Case Report
by: Le Thi My, et al.

Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma
by: Haoying Sun, et al.
Published: (2024-01-01)

Using a nomogram based on preoperative serum fibrinogen levels to predict recurrence of papillary thyroid carcinoma
by: Lei Jianyong, et al.
Published: (2018-04-01)

A Novel and Effective Model to Predict Skip Metastasis in Papillary Thyroid Carcinoma Based on a Support Vector Machine
by: Shuting Zhu, et al.
Published: (2022-07-01)

Preoperative Prediction of Metastatic Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in cN0 Papillary Thyroid Carcinoma
by: Shao J, et al.
Published: (2024-05-01)

Thyroid Langerhans cell histiocytosis concurrent with papillary thyroid carcinoma: A case report and literature review
by: Bin Mi, et al.
Published: (2023-01-01)

Prognostic Significance of BRAF V600E Mutation and CPSF2 Protein Expression in Papillary Thyroid Cancer
by: Irena Ivković, et al.
Published: (2022-12-01)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
by: Adam Stenman, et al.
Published: (2022-02-01)

Predictors of metastasis to lymph nodes posterior to the right recurrent laryngeal nerve in differentiated thyroid carcinoma: A prospective study
by: Ziwen Liu, et al.
Published: (2017-07-01)

Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage
by: Yin-zhu Zhao, et al.
Published: (2022-06-01)

Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
by: Le Ngoc Ha, et al.
Published: (2021-01-01)

Deep Small RNA Sequencing of BRAF V600E Mutated Papillary Thyroid Carcinoma With Lymph Node Metastasis
by: Azliana Mohamad Yusof, et al.
Published: (2019-10-01)

Association of microRNA Expression and BRAF<sup>V600E</sup> Mutation with Recurrence of Thyroid Cancer
by: Daina Pamedytyte, et al.
Published: (2020-04-01)

Genetic and clinical profiles of 160 papillary thyroid cancers with lateral neck lymph node metastasis
by: Yiqiao Fang, et al.
Published: (2023-01-01)

Metastasis of cN0 Papillary Thyroid Carcinoma of the Isthmus to the Lymph Node Posterior to the Right Recurrent Laryngeal Nerve
by: Wei Du, et al.
Published: (2021-05-01)

Association of BRAF V600E immunoexpression with clinicopathological variant groups in papillary thyroid carcinoma
by: Hung Nguyen Van, et al.
Published: (2022-12-01)

Papillary thyroid cancer and cutaneous melanoma: An often underrecognized pair
by: Michelle Chernyak, BS, et al.
Published: (2024-08-01)

Hubungan BRAF V600E dan EGFR dengan Metastasis ke Kelenjar Getah Bening pada Adenokarsinoma Kolorektal
by: Fenny Ariyanni, et al.
Published: (2015-09-01)

Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics
by: Yutong Liu, et al.
Published: (2025-02-01)

BRAF V600E-mutated lung adenocarcinoma with thyroid metastasis as the initial manifestation: a case report
by: Yufei Liu, et al.
Published: (2025-02-01)

Lung Recurrence of Papillary Thyroid Cancer Diagnosed With Antithyroglobulin Antibodies After 10 Years From Initial Treatment
by: David Viola, et al.
Published: (2018-10-01)

Neoadjuvant treatment with lenvatinib and pembrolizumab in a BRAF V600E-mutated anaplastic thyroid cancer: a case report
by: Daniele Barbaro, et al.
Published: (2024-07-01)

Colorectal Cancer with the BRAF V600E Mutation: Two Case Reports and Literature Review
by: Nguyen Cuong Pham, et al.
Published: (2024-09-01)

BRAF V600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm
by: Jennifer A. Silver, et al.
Published: (2021-11-01)

Long-term efficacy of lobectomy for stage T1 papillary thyroid carcinoma with varying degrees of lymph node metastasis
by: Chao Qin, et al.
Published: (2024-08-01)

Clinical Study on Prelaryngeal Lymph Node Metastasis in Papillary Thyroid Carcinoma
by: Gong JX, et al.
Published: (2020-02-01)